Notice Number: NOT-AR-19-011
Key Dates
Release Date: August 30, 2018
NOT-AR-22-024 - Notice of Change to NIAMS Acceptance of Diversity Supplement and Re-Entry Supplement Applications
PA-18-906, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
PA-18-592, Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)
Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Purpose
This Notice is to inform the research community that NIAMS is amending its policy for applications submitted in response to PA-18-586, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)" and PA-18-592, "Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)."
Effective immediately, NIAMS accepts and reviews applications on a continuous basis between October 1 and May 31. Applications received outside of these dates will be returned, but could be resubmitted during the during the next receipt period if appropriate.Inquiries
Please direct all inquiries to:
Marisol Espinoza-Pintucci, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-827-6959
Email: [email protected]
and Human Services (HHS)
